Quarter Period Consolidated Statement Of Comprehensive Income

KAKEN PHARMACEUTIAL CO., LTD. - Filing #7718392

Concept 2018-04-01 to
2018-09-30
2017-04-01 to
2017-09-30
Quarter period consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
8,840,000,000 JPY
10,868,000,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
876,000,000 JPY
1,163,000,000 JPY
Remeasurements of defined benefit plans, net of tax
131,000,000 JPY
222,000,000 JPY
Other comprehensive income
1,008,000,000 JPY
1,385,000,000 JPY
Comprehensive income
9,848,000,000 JPY
12,254,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
9,848,000,000 JPY
12,254,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.